Monarch Capital Management Inc
Source: SEC Form 13F · as of Mar 2026Monarch Capital Management Inc holds 15 biotech & pharma companies tracked by BioSniper, totaling $65.6M in value as of Mar 2026 (SEC Form 13F).
Companies held
15
Total value held
$65.6M
| Company | Shares | Value |
|---|---|---|
| MRKMerck & Co., Inc. | 120,559 | $14.6M |
| JNJJOHNSON & JOHNSON | 58,478 | $14.3M |
| ABBVAbbVie Inc. | 48,772 | $10.6M |
| GILDGILEAD SCIENCES, INC. | 40,107 | $5.6M |
| ABTABBOTT LABORATORIES | 54,260 | $5.6M |
| PFEPFIZER INC | 124,842 | $3.5M |
| ZBHZimmer Biomet Holdings Inc. | 37,388 | $3.4M |
| REGNREGENERON PHARMACEUTICALS, INC. | 3,205 | $2.5M |
| PMPhilip Morris International Inc | 10,530 | $1.8M |
| BMYBRISTOL MYERS SQUIBB CO | 23,965 | $1.5M |
| LLYELI LILLY & Co | 1,130 | $1.0M |
| NVONovo Nordisk A/S | 14,285 | $536K |
| ELVElevance Health Inc. | 1,153 | $338K |
| AMGNAMGEN INC | 760 | $267K |
| NVSNovartis AG | 1,400 | $214K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.